nafld semaglutide improves glucolipid metabolism in T2DM combined with Therapeutic Effects of Glucagon-like Peptide-1

References About this Article Cite this article Article History DOI Journal of Translational Gastroenterology eISSN 2994-8754

Faghris comprehensive research portfolio encompasses the study of occupational health and safety, examining workplace stressors and their impact on chronic diseases such as mental health issues, cardiovascular conditions, obesity, and type 2 diabetes

Here's what makes this litigation significant

When used together, particularly if you are also taking other diabetes medications such as insulin or sulphonylureas (e.g., gliclazide), there is an increased risk of hypoglycaemia (low blood sugar)